HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.

Abstract
Mucinous epithelial ovarian cancers are clinically and morphologically distinct from the other histopathologic subtypes of ovarian cancer. Unlike other ovarian subtypes, epidemiologic studies have indicated that tobacco exposure is a significant risk factor for developing mucinous ovarian cancer. Detection of autoantibody reactivity is useful in biomarker discovery and for explaining the role of important pathophysiologic pathways in disease. In order to study if there are specific antibody biomarkers in the plasma samples of mucinous ovarian cancer patients, we have initiated a screen by employing a 'reverse capture antibody microarray' platform that uses native host antigens derived from mucinous ovarian tissues as 'baits' for the capture of differentially labelled patient and control autoantibodies. Thirty-five autoantibodies that were significantly elevated in the cancer plasma samples compared with healthy controls, and six autoantibodies that segregated smoking and non-smoking patients were identified. Functional annotation of the antibody targets has identified nine target antigens involved in integrin and Wnt signalling pathways. Immunohistochemistry of archived ovarian specimens showed significant overexpression of eight of the nine target antigens in mucinous ovarian tumour tissues, suggesting that plasma autoantibodies from mucinous ovarian cancer patients might have heightened reactivities with epitopes presented by these overexpressed antigens. Autoantibody profiling may have an unexpected utility in uncovering key signalling pathways that are dysregulated in the system of interest.
AuthorsLiangdan Tang, Junzheng Yang, Shu-Kay Ng, Noah Rodriguez, Pui-Wah Choi, Allison Vitonis, Kui Wang, Geoffrey J McLachlan, Robert J Caiazzo Jr, Brian C-S Liu, William R Welch, Daniel W Cramer, Ross S Berkowitz, Shu-Wing Ng
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 46 Issue 1 Pg. 170-9 (Jan 2010) ISSN: 1879-0852 [Electronic] England
PMID19926475 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Neoplasm
  • Antigens, Neoplasm
  • Autoantibodies
  • Biomarkers, Tumor
Topics
  • Adenocarcinoma, Mucinous (immunology)
  • Antibodies, Neoplasm (blood)
  • Antigens, Neoplasm (immunology)
  • Autoantibodies (blood)
  • Biomarkers, Tumor (blood)
  • Enzyme-Linked Immunosorbent Assay (methods)
  • Female
  • Humans
  • Ovarian Neoplasms (immunology)
  • Signal Transduction (immunology)
  • Smoking (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: